Association of IL-6 C-174G (rs 1800795) single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani population

Journal of the Pakistan Medical Association

Volumn 67, Issue 3, 2017, Pages 428-433

  Nadeem, Amina ^a   Mumtaz, Sadaf ^b   Naveed, Abdul Khaliq ^c   Mansoor, Qaiser ^d   Aslam, Muhammad ^e   Siddiqui, Arif ^f   Ismail, Muhammad ^d  

^a ARMY MEDICAL COLLEGE   (Pakistan)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^c Riphah University   (Pakistan)

^d INSTITUTE OF BIOMEDICAL AND GENETIC ENGINEERING IBGE   (Pakistan)

^e UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^f Barrett Hodgson University   (Pakistan)

Author keywords

Diabetes mellitus; Interleukin 6; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAKISTAN; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; ETHNIC GROUP; GENETICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MIDDLE AGED; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85013655135     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Zafar J, Nadeem D, Khan SA, Jawad Abbassi MM, Aziz F, Saeed S. Prevalence of diabetes and its correlation in urban population of Pakistan: A cross-sectional survey. J Pak Med Assoc. 2016; 66: 922-7.
2. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 2010; 53:10-20.
3. Chan KK, Brennan K, You NY, Lu X, Song Y, Hsu Y, et al. Common variations in the genes encoding C-reactive protein, tumor necrosis factor- α and interleukin 6 and risk of clinical diabetes in women’s health initiative observational study. Clin Chem. 2011; 57:317-25.
4. IIIig T, Bongardt F, Schopfer-Wendels A, Huth C, Heid I, Rathmann W. Genetics of type 2 diabetes: impact of interleukin 6 gene variants. Gesundheitswesen. 2005; 67: Suppl 1:122-26.
5. Pedersen BK, Febbraio MA. Muscle as an Endocrine Organ: Focus on Muscle- Derived Interleukin-6. Physiol Rev. 2008; 88:1379-406.
6. Elingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide secretion by increasing glucagon-like peptide from L cells and alpha cells. Nat Med. 2011; 17: 148-9.
7. Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, et al. The interleukin-6 (-174) G/C promoter polymorphism ia associated with type 2 diabetes mellitus in Native Americans and Caucasians. Hum Genet. 2003; 112: 409-13.
8. Stephens JW, Hurel SJ, Lowe GD, Rumley A, Humphries SE. Association between plasma IL-6, the IL-6 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus. Mol Genet Metab. 2007; 90: 422-8.
9. Mukhopadhyaya PN, Acharya A, Chavan Y, Purohit SS, Mutha A. Metagenomic study of single-nucleotide polymorphism within candidate genes associated with type 2 diabetes in an Indian population. Genet Mol Res. 2010; 9: 2060-8.
10. Huth C, IIIig T, Herder C, Geiger C, Grallert H, Vollmert C, et al. Joint analysis of individual participants' data from 17 studies on the association of the IL 6 variant -174G>C with circulating glucose levels, interleukin-6 levels and body mass index. Ann Med. 2009; 41: 128-38.
11. Razquin C, Martinez JA, Martinez-Gonzalez MA, Fernandez-Crehuet J, Santos JM, Marti A. A Mediterranean diet rich in virgin olive oil may reverse the effects of the -174G/C gene variant on 3-year body weight change. Mol Nutr Food Res. 2010; S1: S75-82.
12. Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab. 2004; 89: 1885-90.
13. Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, et al. C-174G Polymorphism in the Promoter of the Interleukin Gene is associated with insulin resistance. Diabetes Care. 2005; 28: 2007-12.
14. Terry CF, Loukasi V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275: 18138-44.
15. Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, et al. IL 6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants' Data from 21 Studies. Diabetes. 2006; 55: 2915-21.
16. Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V, et al. Body composition and -174 G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome.Curr Pharm Des. 2008; 14: 2699-706.
17. Herbert A, Liu C, Karamohamed S, Schiller J, Liu J, Yang Q, et al. The -174 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood institute’s Framingham Heart Study. Diabetologia. 2005; 48: 1492-5.
18. Lu Q, Van-Dam RM, Meigs JB, Manson JE, Hunter D, Hu FB. Genetic variations in IL-6 gene and type 2 diabetes: Tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet. 2006; 15: 1914-20.
19. Kubaszek A, Pihlajamaki J, Punnonen K, Karhappa P, Vauhkonen I, Laakso M.. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity.Diabetes. 2003; 52: 558-61.
20. Saxena M, Srivastava N and Banerjee M. Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus. Mol Biol Rep. 2013; 40: 6271-9.
21. Popko K, Gorska E, Demkow U. Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance. Eur J Med Res. 2010; 15: 123-7.
22. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin 6 gene -174 G>C and -572G>C promoter polymorphism are strong predictors of plasma interleukin 6 levels after coronary artery surgery. Arterioscler Thromb Vasc Biol. 2001; 21: 1458-63.
23. Oberbach A, Lehmann S, Kirsch K, Krist J, Sonnabend M, Linke A, et al. Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene. Eur J Endic. 2008; 159: 129-36.
24. Testa R, Olivieri F, Bonfigli AR, Sirolla C, Boemi M, Marchegiani F, et al.Interleukin 6-174G>C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients. Diabetes Res Clin Pract. 2006; 71: 299-305.
25. Tworowska-Bardzinska U, Kubicka E, Slezak R, Mielcarek M, Bednarek-Tupikowska G, Bolanowski M,. Lack of relationship between 174G_Cpromoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects. Endokrynol Pol. 2009; 60: 172-9.
26. Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Villegas A, Malik S, et al. Genetic polymorphism of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet. 2011; 12:95.